Researchers from as far away as Brisbane, Australia, and Bangkok, Thailand, will participate in a scientific symposium at Vanderbilt University Medical Center on April 28 honoring the memory of the late Al Reynolds, PhD, professor of Pharmacology, emeritus, who died in November, 2022.
The Al Reynolds Memorial Symposium will be held from 1 p.m. to 5 p.m. in Room 208 Light Hall.
The event is hosted by Ege Kavalali, PhD, chair of the Department of Pharmacology, and Ann Richmond, PhD, Ingram Professor and director of the Program for Cancer Biology. Vanderbilt presenters include Robert Carnahan, PhD, Robert Coffey, MD, and Nick Markum, MD, PhD.
Reynolds’ research interests included the Rous Sarcoma Virus-derived oncogene, Src, and p120, a substrate of Src that is a crucial regulatory element of E-cadherin, which is a protein necessary for maintaining contact between cells. He was often referred to as the “Father of p120”.
He was a former director of the Cancer Biology Graduate Program and of the Program in Signal Transduction and Cell Proliferation at the Vanderbilt-Ingram Center and served as executive director of the Vanderbilt Antibody and Protein Core between 2009 and 2017. He was a valued collaborator and mentor.
For more information about the symposium, contact ann.richmond@vanderbilt.edu.
